Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04878783

Radiomics and Molecular Expression Predictive Model for Esophago-Gastric Junction and Gastric Cancer TRG

CT Scan-Based Radiomics and Molecular Expression Predictive Model to Assess Tumor Regression Grade Following Perioperative Chemotherapy in Esophago-Gastric Junction and Gastric Cancer

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
138 (actual)
Sponsor
University of Roma La Sapienza · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

The aim of this study is to develop a CT scan-based radiomics predictive model about tumor regression grade (TRG) in patients with esophago-gastric junction (EGJ) ang gastric cancer undergoing perioperative chemotherapy. The molecular expression of the neoplasms will be evaluated to assess its association with the TRG and the radiomic features.

Detailed description

• To compare the radiomic features of the CT scans at the time of diagnosis (T0) and at the end of the preoperative chemotherapy (T1) in order to predict the TRG with the texture analysis on the first CT scan. A non-good response (non-GR) has shown to be predictable with texture analysis on the pre-treatment CT scan. Therefore, we hypothesize that texture analysis could let to identify the good response patients. • To find correlation between the molecular expression of the tumor and the radiomics features. Texture analysis on the pre-chemotherapy CT scan founded that entropy and compactness were higher and uniformity lower in responders. Nonetheless the association between radiomics features and molecular expression has not been investigated yet. Therefore, we hypothesize to add some others radiomics signatures to the analysis and to find an association with the molecular expression. • To find correlation between the molecular expression of the tumor and the TRG. MSI gastric cancer has been shown to be less responsive to preoperative chemotherapy. Therefore, we hypothesize to confirm this result.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCT scanPatients undergoing CT scan staging for gastric and EJ junction cancer + perioperative chemotherapy (FLOT regimen) , CT scan re-staging and radical gastrectomy or esophagogastrectomy will be enrolled in the study

Timeline

Start date
2019-12-20
Primary completion
2024-10-01
Completion
2027-10-30
First posted
2021-05-07
Last updated
2024-05-09

Locations

5 sites across 2 countries: Italy, Netherlands

Source: ClinicalTrials.gov record NCT04878783. Inclusion in this directory is not an endorsement.